Danske Invest

MediLife Fund D

Morningstar Rating : - Funds promoting environmental or social characteristics - ISIN: FI0008802954
Documents
Factsheet
Key Information Document (PRIIPs)
Price list
Fund regulations
Investor notification
Prospectus
Sustainability-related disclosure
Investor rights

1.12801

NAV as of 23.04.2024

+1.47%

Return 1 day

-1.13%

Return 1 month

+8.26%

Return (year-to-date)

Objectives and investment policy

Objectives

The target of investment activities is to achieve long-term value increase on the invested assets through active asset management pursuant to the Act on Common Funds and the fund's regulations.

Investment policy

The assets are invested in publicly traded equities and equity-linked securities of pharmaceutical, healthcare and biotechnology companies globally. The assets may also be invested in securities whose issuer's primary business is related to ageing or quality of life, or serves or supports these sectors. The fund is categorised as article 8 under SFDR and promotes environmental and/or social characteristics, as well as good governance practices, through screening, exclusions, investment analysis and decision-making as well as active ownership. The fund follows Danske Invest's responsible investment policy. The returns on the fund's investments, such as dividends and interest, will be reinvested. The fund's base currency is the euro.

It is generally expected that the fund's holdings, and therefore its performance, may differ significantly from those of the benchmark. The fund is suitable for investors who wish to invest globally in pharmaceutical and other healthcare sector companies and who seek high returns, while tolerating substantial value fluctuations or even decreases. The fund is suitable as part of a diversified investment portfolio. Investors may subscribe for and redeem fund units on every banking day.


Recommendation: This fund may not be appropriate for investors who plan to withdraw their money within 7 years.

Funds promoting environmental or social characteristics (Article 8)
This type of fund promotes environmental (E) or social (S) conditions and ensures good governance practices (G). Depending on the fund's investment strategy, this may be done through screening, exclusion, inclusion and active ownership. The funds may partially invest in sustainable investments, but making sustainable investments is not their goal.
Funds that promote environmental or social characteristics are subject to the disclosure requirements set out in Article 8 of the EU's regulation on sustainability-related disclosures in the financial services sector.

Return

MediLife Fund D
Benchmark
Return
Monthly return
Annual return
Return (12 M rolling)
Monthly excess return compared to benchmark
1 year
3 years
5 years
10 years
Since launch

to
Compare with other fund ...
2030 Fund DDanske Invest
2030 Fund GDanske Invest
2040 Fund DDanske Invest
2040 Fund GDanske Invest
Bond Fund DDanske Invest
Bond Fund GDanske Invest
Bond Fund I DDanske Invest
Bond Fund I GDanske Invest
China Fund DDanske Invest
China Fund GDanske Invest
Compass 25 Fund DDanske Invest
Compass 25 Fund GDanske Invest
Compass 50 Fund DDanske Invest
Compass 50 Fund GDanske Invest
Compass 75 Fund DDanske Invest
Compass 75 Fund GDanske Invest
Compass Equity Fund DDanske Invest
Compass Equity Fund GDanske Invest
Compass Liquidity Fund DDanske Invest
Compass Liquidity Fund GDanske Invest
ESG Equities Fund DDanske Invest
ESG Equities Fund GDanske Invest
Eastern Europe Convergence Fund DDanske Invest
Eastern Europe Convergence Fund GDanske Invest
Emerging Markets Debt Fund D (AIF)Danske Invest
Emerging Markets Debt Fund G (AIF)Danske Invest
Emerging Markets Sustainable Future Class ADanske Invest SICAV
Emerging Markets Sustainable Future Fund DDanske Invest
Emerging Markets Sustainable Future Fund GDanske Invest
Euro Corporate Bond Fund DDanske Invest
Euro Corporate Bond Fund GDanske Invest
Euro Government Bond Index Fund GDanske Invest
Euro High Yield Fund DDanske Invest
Euro High Yield Fund GDanske Invest
Europe High Dividend Fund DDanske Invest
Europe High Dividend Fund GDanske Invest
Europe Small Cap Fund DDanske Invest
Europe Small Cap Fund GDanske Invest
European Corporate Sustainable Bond Class ADanske Invest SICAV
European Equity Fund DDanske Invest
European Equity Fund GDanske Invest
Finnish Equity Fund DDanske Invest
Finnish Equity Fund GDanske Invest
Finnish Equity Fund I DDanske Invest
Finnish Equity Fund I GDanske Invest
Global Corporate Sustainable Bond Class ADanske Invest SICAV
Global Emerging Markets, osuuslaji EURDanske Invest
India Fund DDanske Invest
India Fund GDanske Invest
Institutional Liquidity Fund DDanske Invest
Institutional Liquidity Fund GDanske Invest
Institutional Liquidity Plus Fund DDanske Invest
Institutional Liquidity Plus Fund GDanske Invest
Japanese Equity Fund DDanske Invest
Japanese Equity Fund GDanske Invest
Kehittyvät Korkomarkkinat Paikallisvaluutta, osuuslaji EUR WDanske Invest
Kehittyvät Korkomarkkinat, paikallisvaluutta, osuuslaji EURDanske Invest
Liquidity Fund DDanske Invest
Liquidity Fund GDanske Invest
MediLife Fund GDanske Invest
Multi Asset Inflation Strategy Class ADanske Invest SICAV
Nordic Corporate Bond Plus Fund DDanske Invest
Nordic Corporate Bond Plus Fund GDanske Invest
Pohjoisen Yrityslainat, osuuslaji EUR hDanske Invest
Reaalikorko Maailma, osuuslaji EUR hDanske Invest
Technology Index Fund DDanske Invest
Technology Index Fund GDanske Invest
USA Index Fund DDanske Invest
USA Index Fund GDanske Invest
USA Index Fund I DDanske Invest
USA Index Fund I GDanske Invest
Past performance is not a reliable indicator of future results. Future returns may be negative. The return may increase and decrease as a result of currency fluctuations if the fund is issued in a currency other than the currency used in the country in which you are domiciled.

Risk indicator

Lower risk

Higher risk

Typically lower return

Typically higher return

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

The summary risk indicator is a guide to the level of risk of this product compared to other products. It shows how likely it is that the product will lose money because of movements in the markets or because we are not able to pay you.

This classification may change and may not reliably indicate the future risk profile of the fund. The lowest category does not mean risk free.

This product does not include any protection from future market performance so you could lose some or all of your investment.
 

Value of
Click to change the amount

0 years
years
10 years
years

of which n/a € in dividends.
Total charges during the period:
n/a €.

Past performance is not a reliable indicator of future results. Future returns may be negative. The return may increase and decrease as a result of currency fluctuations if the fund is issued in a currency other than the currency used in the country in which you are domiciled.
Show table

Value of EUR 100

PeriodeVærdi
1 year runningEUR 116.60
3 years runningEUR 132.93
5 years runningEUR 169.74
7 years runningEUR 195.67
10 years runningEUR 315.75
Past performance is not a reliable indicator of future results. Future returns may be negative. The return may increase and decrease as a result of currency fluctuations if the fund is issued in a currency other than the currency used in the country in which you are domiciled.
Show calculator

Manager

Allianz: Christopher Chin

Allianz Global Investors is a global asset management company with offices in over 20 locations worldwide. The company is owned by Allianz Asset Management AG, which in turn is owned by the German insurance company Allianz SE. 

Allianz Global Investors manage almost €600 billion in assets for individuals, families, and institutions. The parent company, Allianz SE, is one of the leading financial services providers worldwide with almost 130 years of asset management expertise.

Allianz invest for the long term and seek to generate value for clients every step of the way. They do this by being active – in how they partner with clients and anticipate their changing needs, and build solutions based on capabilities across public and private markets. Allianz’s focus on protecting and enhancing their clients’ assets leads naturally to a commitment to sustainability to drive positive change.

Asset allocation as of 29.02.2024


Please note that all holdings are delayed with 1 month.
MediLife Fund D

Holdings as of 29.02.2024

Name of investment/security Weight Type Currency Country ISIN code
Eli Lilly & Co. 000000000000009.659.65% Equities USD USA US5324571083
Novo Nordisk B (ADR) 000000000000006.316.31% Equities USD USA US6701002056
AbbVie Inc. 000000000000005.245.24% Equities USD USA US00287Y1091
Merck & Co. Inc. 000000000000004.814.81% Equities USD USA US58933Y1055
UnitedHealth Group Inc. 000000000000004.734.73% Equities USD USA US91324P1021
Thermo Fisher Scientific Inc. 000000000000004.454.45% Equities USD USA US8835561023
Abbott Laboratories 000000000000003.723.72% Equities USD USA US0028241000
AstraZeneca Plc (ADR) 000000000000003.643.64% Equities USD USA US0463531089
Boston Scientific Corp. 000000000000003.243.24% Equities USD USA US1011371077
Amgen Inc. 000000000000002.972.97% Equities USD USA US0311621009
Please note that all holdings are delayed with 1 month.

Charges

The charges you pay are used to cover the costs of running the fund, including marketing costs and distribution. These charges reduce the potential growth of your investment.

Charges taken from the fund over a year

One-off charges taken before or after you invest

Other charges *)

*) Other charges are charges which entirely or partially are included in the ongoing charges and/or one-off charges.
MediLife Fund D

Facts about the fund & dividends

  • Dividend per unit

    Dividend per unit

    Dividend date Payment date Dividend type Amount
    16.04.2024 - Normal EUR 0.0433
    28.03.2023 - Normal EUR 0.04398
    05.04.2022 - Normal EUR 0.04888
    13.04.2021 - Normal EUR 0.03774
    15.04.2020 - Normal EUR 0.03817
  • Basic information

    Basic information

    ISIN code FI0008802954
    Listed on stock exchange No
    Sub-fund of Danske Invest
    Fund domicile Finland
    Dividends Yes
    Management company Danske Invest Fund Management Ltd
    Man. company domicile Finland
    Depositary Skandinaviska Enskilda Banken AB (publ) Helsinki branch
    Minimum initial investment 10 EUR
    Currency EUR
    Price method Single Price
    Legal type UCITS
    Launch date 16.08.2000
    Bloomberg ticker MANMEDT FH
    Marketing permission Finland
    Class of Danske Invest MediLife
    Other classes MediLife Fund G
    MediLife Fund W D
    MediLife Fund W G
    MediLife K
    MediLife T
    MediLife W A
    MediLife W K
    MediLife W T
  • Profile

    Profile

    Profile Actively managed
    Type Equity
    Investment area Global
    Benchmark MSCI Health Care (TR) Index
    Recommended investment horizon 7 years
  • Today's figures

    Today's figures

    Total assets, mill. EUR as of 23.04.2024 113.14
    Shareclass total assets, mill. EUR as of 23.04.2024 0.59
    Net asset value (NAV) EUR as of 23.04.2024 1.12801
  • Risk key figures as of 28.03.2024

    Risk key figures as of 28.03.2024

      1 year 3 years 5 years 7 years 10 years
    Avg. annual return (%) 16.60 9.95 11.16 10.06 12.18
    Sharpe Ratio 0.65 0.78 0.72 0.78
    Volatility 12.21 12.66 12.80 14.42
    Tracking Error 3.50 3.75 3.98 4.34
    Information Ratio -0.39 -0.15 -0.17 -0.06
    Calculation is based on end-of-month data.
  • Download documents

Info

Noget gik galt.

Warning

Noget gik galt.

Error

Noget gik galt.